Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001237268 | SCV001410022 | uncertain significance | Leber congenital amaurosis 2; Retinitis pigmentosa 20 | 2022-08-10 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 520 of the RPE65 protein (p.Ile520Thr). This variant is present in population databases (rs281865291, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with RPE65-related conditions. ClinVar contains an entry for this variant (Variation ID: 98849). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Retina International | RCV000085177 | SCV000117314 | not provided | not provided | no assertion provided | not provided | ||
Natera, |
RCV001826774 | SCV002092730 | uncertain significance | Leber congenital amaurosis | 2020-03-16 | no assertion criteria provided | clinical testing |